[1]
|
Bader, A.G., Brown, D., Stoudemire, J. and Lammers, P. (2011) Developing Therapeutic microRNAs for Cancer. Gene Therapy, 18, 1121-1126. https://doi.org/10.1038/gt.2011.79
|
[2]
|
Liu, J., Zhang, K.S., Hu, B., Li, S.G., Li, Q., Luo, Y.P., Wang, Y. and Deng, Z.F. (2018) Systematic Analysis of RNA Regulatory Network in Rat Brain after Ischemic Stroke. BioMed Research International, 8354350.
https://doi.org/10.1155/2018/8354350
|
[3]
|
Ambrogini, P., Albertini, M.C., Betti, M., Galati, C., Lattanzi, D., et al. (2018) Neurobiological Correlates of Alpha-Tocopherol Antiepileptogenic Effects and MicroRNA Expression Modulation in a Rat Model of Kainate-Induced Seizures. Molecular Neurobiology, 2.
|
[4]
|
Ding, H.X., Huang, Z., Chen, M.J., Wang, C., Chen, X., Chen, J.N., et al. (2016) Identification of a Panel of Five Serum miRNAs as a Biomarker for Parkinson’s Disease. Parkinsonism & Related Disorders, 22, 68-73.
https://doi.org/10.1016/j.parkreldis.2015.11.014
|
[5]
|
Mizushima, N. and Komatsu, M. (2011) Autophagy: Ren-ovation of Cells and Tissues. Cell, 147, 728-741.
https://doi.org/10.1016/j.cell.2011.10.026
|
[6]
|
Lynch-Day, M.A., Mao, K., Wang, K., Zhao, M. and Klionsky, D.J. (2012) The Role of Autophagy in Parkinson’s Disease. Cold Spring Harbor Perspectives in Medicine, 2, a009357. https://doi.org/10.1101/cshperspect.a009357
|
[7]
|
Gozuacik, D., Akkoc, Y., Ozturk, D.G. and Kocak, M. (2017) Autophagy-Regulating microRNAs and Cancer. Frontiers in Oncology, 7, 65. https://doi.org/10.3389/fonc.2017.00065
|
[8]
|
Gallo, K.A. and Johnson, G.L. (2002) Mixed-Lineage Kinase Control of JNK and p38 MAPK Pathways. Nature Reviews Molecular Cell Biology, 3, 663-672. https://doi.org/10.1038/nrm906
|
[9]
|
Xi, Y.M., Dong, Y.F., Wang, Z.J., Liu, Y., Diao, Z.Z. and Hu, Y.G. (2013) Co-Transfection of Adeno-Associated Virus-Mediated Human Vascular Endothelial Growth Factor(165) and Trans-forming Growth Factor-Beta 1 into Annulus Fibrosus Cells of Rabbit Degenerative Intervertebral Discs. Genetics and Molecular Research, 12, 4895-4908.
https://doi.org/10.4238/2013.February.28.11
|
[10]
|
Liu, Y., Song, Y.F. and Zhu, X.T. (2017) MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson’s Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways. Medical Science Monitor, 23, 1597-1606. https://doi.org/10.12659/MSM.900218
|
[11]
|
Song, M.K., Park, Y.K. and Ryu, J.C. (2013) Polycyclic Aromatic Hydrocarbon (PAH)-Mediated Upregulation of Hepatic microRNA-181 Family Promotes Cancer Cell Migration by Targeting MAPK Phosphatase-5, Regulating the Activation of p38 MAPK. Toxicology and Applied Pharmacology, 273, 130-139.
https://doi.org/10.1016/j.taap.2013.08.016
|
[12]
|
Wei, M., Cao, L.J., Zheng, J.L., Xue, L.J., Chen, B., Xiao, F., et al. (2017) MicroRNA-181c Functions as a Protective Factor in a 1-Methyl-4-Phenylpyridinium Iodide-Induced Cellular Parkinson’s Disease Model via BCL2L11. European Review for Medical and Pharmacological Sciences, 21, 3296-3304.
|
[13]
|
Mishima, T., Mizuguchi, Y., Kawahigashi, Y., Takizawa, T. and Takizawa, T. (2007) RT-PCR-Based Analysis of microRNA (miR-1 and -124) Expression in Mouse CNS. Brain Research, 1131, 37-43.
https://doi.org/10.1016/j.brainres.2006.11.035
|
[14]
|
Ponomarev, E.D., Veremeyko, T., Barteneva, N., Krichevsky, A.M. and Weiner, H.L. (2011) MicroRNA-124 Promotes Microglia Quiescence and Suppresses EAE by Deactivating Macrophages via the C/EBP-alpha-PU.1 Pathway. Nature Medicine, 17, 64-70. https://doi.org/10.1038/nm.2266
|
[15]
|
Doeppner, T.R., Doehring, M., Bretschneider, E., Zechariah, A., Kaltwasser, B., Muller, B., et al. (2013) MicroRNA-124 Protects against Focal Cerebral Ischemia via Mechanisms Involving Usp14-Dependent REST Degradation. Acta Neuropathologica, 126, 251-265. https://doi.org/10.1007/s00401-013-1142-5
|
[16]
|
Sun, Y., Gui, H., Li, Q., Luo, Z.M., Zheng, M.J., Duan, J.L., et al. (2013) MicroRNA-124 Protects Neurons against Apoptosis in Cerebral Ischemic Stroke. CNS Neuroscience & Therapeutics, 19, 813-819.
https://doi.org/10.1111/cns.12142
|
[17]
|
Kanagaraj, N., Beiping, H., Dheen, S.T. and Tay, S.S. (2014) Downregu-lation of miR-124 in MPTP-Treated Mouse Model of Parkinson’s Disease and MPP Iodide-Treated MN9D Cells Mod-ulates the Expression of the Calpain/cdk5 Pathway Proteins. Neuroscience, 272, 167-179. https://doi.org/10.1016/j.neuroscience.2014.04.039
|
[18]
|
Wang, H., Ye, Y., Zhu, Z., Mo, L., Lin, C., Wang, Q., et al. (2016) MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson’s Disease by Targeting to Bim. Brain Pathology, 26, 167-176.
https://doi.org/10.1111/bpa.12267
|
[19]
|
Bove, J., Martinez-Vicente, M., Dehay, B., Perier, C., Recasens, A., Bombrun, A., et al. (2014) BAX Channel Activity Mediates Lysosomal Disruption Linked to Parkinson Disease. Au-tophagy, 10, 889-900.
https://doi.org/10.4161/auto.28286
|
[20]
|
Perier, C., Bove, J., Wu, D.C., Dehay, B., Choi, D.K., Jackson-Lewis, V., et al. (2007) Two Molecular Pathways initiate Mitochondria-Dependent Dopaminergic Neurodegeneration in Experimental Parkinson’s Disease. Proceedings of the National Academy of Sciences of the United States of America, 104, 8161-8166.
https://doi.org/10.1073/pnas.0609874104
|
[21]
|
Doxakis, E. (2010) Post-Transcriptional Regulation of Alpha-Synuclein Expression by mir-7 and mir-153. The Journal of Biological Chemistry, 285, 12726-12734. https://doi.org/10.1074/jbc.M109.086827
|
[22]
|
Junn, E., Lee, K.W., Jeong, B.S., Chan, T.W., Im, J.Y. and Mouradian, M.M. (2009) Repression of Alpha-Synuclein Expression and Toxicity by microRNA-7. Proceedings of the National Academy of Sciences of the United States of America, 106, 13052-13057. https://doi.org/10.1073/pnas.0906277106
|
[23]
|
Fragkouli, A. and Doxakis, E. (2014) miR-7 and miR-153 Protect Neurons against MPP(+)-Induced Cell Death via Upregulation of mTOR Pathway. Frontiers in Cellular Neuroscience, 8, 182. https://doi.org/10.3389/fncel.2014.00182
|
[24]
|
Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T., Acevedo-Arozena, A., Adeli, K., et al. (2012) Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy. Autophagy, 8, 445-544.
https://doi.org/10.4161/auto.19496
|
[25]
|
Rosenfeldt, M.T. and Ryan, K.M. (2009) The Role of Autophagy in Tumour Development and Cancer Therapy. Expert Reviews in Molecular Medicine, 11, e36. https://doi.org/10.1017/S1462399409001306
|
[26]
|
Scott, R.C., Schuldiner, O. and Neufeld, T.P. (2004) Role and Regulation of Starvation-Induced Autophagy in the Drosophila Fat Body. Developmental Cell, 7, 167-178. https://doi.org/10.1016/j.devcel.2004.07.009
|
[27]
|
Rubinsztein, D.C. (2010) Autophagy: Where Next? EMBO Reports, 11, 3. https://doi.org/10.1038/embor.2009.253
|
[28]
|
Lee, E.J. and Tournier, C. (2011) The Requirement of Uncoordinated 51-Like Kinase 1 (ULK1) and ULK2 in the Regulation of Autophagy. Autophagy, 7, 689-695. https://doi.org/10.4161/auto.7.7.15450
|
[29]
|
Jung, C.H., Jun, C.B., Ro, S.H., Kim, Y.M., Otto, N.M., Cao, J., et al. (2009) ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery. Molecular Biology of the Cell, 20, 1992-2003.
https://doi.org/10.1091/mbc.E08-12-1249
|
[30]
|
Chen, Y., Wang, S.Y., Zhang, L., Xie, T., Song, S.C., Huang, J., et al. (2015) Identification of ULK1 as a Novel Biomarker Involved in miR-4487 and miR-595 Regulation in Neuroblastoma SH-SY5Y Cell Autophagy. Scientific Reports, 5, Article No. 11035.
|
[31]
|
Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., et al. (2011) MicroRNA Profiling of Parkinson’s Disease Brains Identifies Early Downregulation of miR-34b/c Which Modulate Mitochondrial Function. Human Molecular Genetics, 20, 3067-3078. https://doi.org/10.1093/hmg/ddr210
|
[32]
|
Xiong, R., Wang, Z., Zhao, Z., Li, H., Chen, W., Zhang, B., et al. (2014) MicroRNA-494 Reduces DJ-1 Expression and Exacerbates Neurodegeneration. Neurobiology of Aging, 35, 705-714.
https://doi.org/10.1016/j.neurobiolaging.2013.09.027
|
[33]
|
Scholz, S.W., Mhyre, T., Ressom, H., Shah, S. and Federoff, H.J. 2012 (2012) Genomics and Bioinformatics of Parkinson’s Disease. Cold Spring Harbor Perspectives in Medicine, 2, a009449.
https://doi.org/10.1101/cshperspect.a009449
|
[34]
|
Shendelman, S., Jonason, A., Martinat, C., Leete, T. and Abeliovich, A. (2004) DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits Alpha-Synuclein Aggregate Formation. PLOS Biology, 2, 1764-1773.
https://doi.org/10.1371/journal.pbio.0020362
|
[35]
|
Alvarez-Erviti, L., Seow, Y., Schapira, A.H.V., Rodriguez-Oroz, M.C., Obeso, J.A. and Cooper, J.M. (2013) Influence of microRNA Deregulation on Chaperone-Mediated Autophagy and Alpha-Synuclein Pathology in Parkinson’s Disease. Cell Death & Disease, 4, e545.
|